{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:27:45Z","timestamp":1792931265209,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jaad.2018.03.056","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T20:55:06Z","timestamp":1523652906000},"page":"1199-1213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Hair disorders in cancer survivors"],"prefix":"10.1016","volume":"80","author":[{"given":"Azael","family":"Freites-Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"van den Hurk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin J.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Paus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario E.","family":"Lacouture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2018.03.056_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/1055-9965.EPI-12-1356","article-title":"Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care","volume":"22","author":"de Moor","year":"2013","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.jaad.2018.03.056_bib3","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2018.03.056_bib4","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaad.2018.03.056_bib5","first-page":"83","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaad.2018.03.056_bib6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/1055-9965.EPI-14-1418","article-title":"Survivors of childhood cancer in the United States: prevalence and burden of morbidity","volume":"24","author":"Phillips","year":"2015","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.jaad.2018.03.056_bib7","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1158\/1055-9965.EPI-12-0740","article-title":"Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey","volume":"21","author":"Weaver","year":"2012","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.jaad.2018.03.056_bib8","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.03.056_bib9","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1200\/JCO.2011.39.3611","article-title":"Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor study","volume":"30","author":"Kinahan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2018.03.056_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx655.022","article-title":"Incidence of permanent chemotherapy-induced alopecia among breast cancer patients: a five-year prospective cohort study [abstract]","volume":"28","author":"Kang","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2018.03.056_bib11","first-page":"1461","article-title":"Unanticipated toxicities from anticancer therapies: survivors' perspectives","volume":"18","author":"Gandhi","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jaad.2018.03.056_bib12","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1158\/0008-5472.SABCS-09-3174","article-title":"Long term persistent alopecia and suboptimal hair regrowth after adjuvant chemotherapy for breast cancer: alert for an emerging side effect: ALOPERS observatory","volume":"69","author":"Bourgeois","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2018.03.056_bib13","first-page":"viii83","article-title":"Long term persistent alopecia and suboptimal hair regrowth after adjuvant chemotherapy for breast cancer: alert for an emerging side effect: French alopers observatory","volume":"21","author":"Bourgeois","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2018.03.056_bib14","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1111\/ajd.12350","article-title":"Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil","volume":"57","author":"Yang","year":"2016","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib15","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2133.2005.06469.x","article-title":"Permanent alopecia after busulfan chemotherapy","volume":"152","author":"Tosti","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib16","first-page":"13","article-title":"Permanent alopecia in women being treated for breast cancer","volume":"13","author":"Masidonski","year":"2009","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.jaad.2018.03.056_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaad.2009.06.063","article-title":"Permanent chemotherapy-induced alopecia: case report and review of the literature","volume":"63","author":"Tallon","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/DAD.0b013e3181fcfc25","article-title":"Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases","volume":"33","author":"Miteva","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2018.03.056_bib19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2010.03.020","article-title":"Permanent chemotherapy-induced alopecia: a review","volume":"64","author":"Palamaras","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"24 suppl","key":"10.1016\/j.jaad.2018.03.056_bib20","article-title":"Permanent chemotherapy induced alopecia in\u00a0early breast cancer patients after (neo)adjuvant chemotherapy: long term follow up","volume":"73","author":"Bertrand","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2018.03.056_bib21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/ced.12596","article-title":"Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure","volume":"40","author":"Champagne","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10549-017-4204-x","article-title":"Chemotherapy-induced irreversible alopecia in early breast cancer patients","volume":"163","author":"Kim","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jaad.2018.03.056_bib23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1684\/ejd.2008.0617","article-title":"Irreversible alopecia due to busulphan in a 7-year-old girl","volume":"19","author":"Perez-Crespo","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2133.2009.09043.x","article-title":"Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer","volume":"160","author":"Prevezas","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib25","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jaad.2016.12.027","article-title":"Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: clinicopathologic findings in a cohort of 10 patients","volume":"76","author":"Fonia","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 4","key":"10.1016\/j.jaad.2018.03.056_bib26","article-title":"Irriversible chemotherapy-induced alopecia in breast cancer patient","volume":"76","author":"Kim","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2018.03.056_bib27","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/annonc\/mds095","article-title":"Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil\/epirubicin\/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients","volume":"23","author":"Kluger","year":"2012","journal-title":"Ann Oncol"},{"issue":"suppl","key":"10.1016\/j.jaad.2018.03.056_bib28","article-title":"Long term hair loss in patients with early breast cancer receiving docetaxel chemotherapy","volume":"75","author":"Thorp","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2018.03.056_bib29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","article-title":"Permanent chemotherapy-induced alopecia in patients with breast cancer: a 3-year prospective cohort study","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.jaad.2018.03.056_bib30","first-page":"43","article-title":"Busulphan\/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth","volume":"7","author":"Baker","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2018.03.056_bib31","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1590\/abd1806-4841.20154013","article-title":"Clinical and histological study of permanent alopecia after bone marrow transplantation","volume":"90","author":"Basilio","year":"2015","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib32","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/bmt.2017.15","article-title":"Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood","volume":"52","author":"Bresters","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2018.03.056_bib33","first-page":"869","article-title":"Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants","volume":"15","author":"Ljungman","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2018.03.056_bib34","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bmt.1705817","article-title":"Six cases of permanent alopecia after various conditioning regimens commonly used in hematopoietic stem cell transplantation","volume":"40","author":"Machado","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2018.03.056_bib35","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V98.13.3569","article-title":"Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies","volume":"98","author":"Soci\u00e9","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.03.056_bib36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1440-0960.2000.00405.x","article-title":"Permanent alopecia following chemotherapy and bone marrow transplantation","volume":"41","author":"Tran","year":"2000","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib37","first-page":"S219","article-title":"Permanent alopecia is a common late effect of hematopoietic stem cell transplantation, especially in younger children and after busulfan conditioning","volume":"51","author":"Bresters","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2018.03.056_bib38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.bmt.1703695","article-title":"Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy","volume":"30","author":"de Jonge","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2018.03.056_bib39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-018-4855-2","article-title":"Persistent major alopecia following adjuvant docetaxel for\u00a0breast cancer: incidence, characteristics, and prevention with scalp cooling","volume":"171","author":"Martin","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jaad.2018.03.056_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13014-015-0547-9","article-title":"Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: a prospective analysis","volume":"10","author":"Cox","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jaad.2018.03.056_bib41","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/pbc.24554","article-title":"Acute toxicity of proton beam radiation for pediatric central nervous system malignancies","volume":"60","author":"Suneja","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaad.2018.03.056_bib42","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/pbc.20689","article-title":"Surgical interventions for the treatment of radiation-induced alopecia in pediatric practice","volume":"49","author":"Rannan-Eliya","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaad.2018.03.056_bib43","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijrobp.2004.04.031","article-title":"Permanent alopecia after cranial irradiation: dose-response relationship","volume":"60","author":"Lawenda","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaad.2018.03.056_bib44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13014-014-0220-8","article-title":"Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation","volume":"9","author":"Min","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jaad.2018.03.056_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1471-2407-12-283","article-title":"Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases","volume":"12","author":"Steinmann","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jaad.2018.03.056_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2310\/7750.2012.12033","article-title":"Radiation- and chemotherapy-induced permanent alopecia: case series","volume":"17","author":"Haider","year":"2013","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2018.03.056_bib47","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3892\/mco.2017.1155","article-title":"Clinical outcome and dose volume evaluation in patients who undergo brachytherapy for angiosarcoma of the scalp and face","volume":"6","author":"Sanada","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.jaad.2018.03.056_bib48","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0360-3016(96)00145-9","article-title":"Local control and functional results after twice-daily radiotherapy for Ewing's sarcoma of the extremities","volume":"35","author":"Bolek","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaad.2018.03.056_bib49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/95.2.142","article-title":"Quantitative association between HER-2\/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer","volume":"95","author":"Konecny","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2018.03.056_bib50","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1200\/JCO.2013.54.2258","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update","volume":"32","author":"Burstein","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2018.03.056_bib51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1758834016687260","article-title":"A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy","volume":"9","author":"Sousa","year":"2017","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jaad.2018.03.056_bib52","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5301\/tj.5000376","article-title":"Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?","volume":"101","author":"Moscetti","year":"2015","journal-title":"Tumori"},{"key":"10.1016\/j.jaad.2018.03.056_bib53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10549-013-2744-2","article-title":"Aromatase inhibitor therapy and hair loss among breast cancer survivors","volume":"142","author":"Gallicchio","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jaad.2018.03.056_bib54","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1634\/theoncologist.2013-0193","article-title":"Alopecia with endocrine therapies in patients with cancer","volume":"18","author":"Saggar","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.jaad.2018.03.056_bib55","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","article-title":"Endocrine therapy-induced alopecia in patients with breast cancer","volume":"154","author":"Freites-Martinez","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib56","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/annonc\/mdt170","article-title":"Aromatase inhibitors induce \u2018male pattern hair loss\u2019 in women?","volume":"24","author":"Rossi","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2018.03.056_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/0974-7753.58555","article-title":"Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria","volume":"1","author":"Rakowska","year":"2009","journal-title":"Int J Trichol"},{"key":"10.1016\/j.jaad.2018.03.056_bib58","first-page":"799","article-title":"Tamoxifen-induced hirsutism","volume":"10","author":"Al-Niaimi","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib59","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/PRS.0b013e3181babc49","article-title":"Refinements of tissue expansion for pediatric forehead reconstruction: a 13-year experience","volume":"124","author":"Gosain","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2018.03.056_bib60","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijsu.2017.05.033","article-title":"Prognostic factors in patients treated with surgery for brain metastases: a single-center retrospective analysis of 125 patients","volume":"44","author":"Liu","year":"2017","journal-title":"Int J Surg"},{"key":"10.1016\/j.jaad.2018.03.056_bib61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10549-017-4309-2","article-title":"Identifying long-term survivors among metastatic breast cancer patients undergoing primary tumor surgery","volume":"165","author":"Yoo","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jaad.2018.03.056_bib62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-0037-1601874","article-title":"Brain metastases of non-small cell lung cancer: prognostic factors in patients with surgical resection","volume":"79","author":"Antu\u00f1a","year":"2018","journal-title":"J Neurol Surg A Cent Eur Neurosurg"},{"key":"10.1016\/j.jaad.2018.03.056_bib63","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/00006123-200010000-00018","article-title":"Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors","volume":"47","author":"Albright","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jaad.2018.03.056_bib64","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1470-2045(15)00581-1","article-title":"Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis","volume":"17","author":"Thompson","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2018.03.056_bib65","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1524-4725.1999.98257.x","article-title":"Keloids and hypertrophic scars","volume":"25","author":"English","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2018.03.056_bib66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2001-12686","article-title":"Oral-cavity hair growth after free-flap transfer: case report","volume":"17","author":"Endo","year":"2001","journal-title":"J Reconstr Microsurg"},{"key":"10.1016\/j.jaad.2018.03.056_bib67","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.bjorl.2017.04.009","article-title":"Free tissue flaps in head and neck reconstruction: clinical application and analysis of 93 patients of a single institution","volume":"84","author":"Liang","year":"2018","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.jaad.2018.03.056_bib68","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/DSS.0000000000001131","article-title":"Intraoral laser hair removal of a palate free flap: tips and technique","volume":"44","author":"Yan","year":"2018","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2018.03.056_bib69","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/bjd.13630","article-title":"Persistent alopecia induced by vismodegib","volume":"172","author":"Alkeraye","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib70","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/bjd.15237","article-title":"Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors","volume":"176","author":"Zarbo","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib71","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3325\/cmj.2016.57.229","article-title":"High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease","volume":"57","author":"Ceovic","year":"2016","journal-title":"Croat Med J"},{"key":"10.1016\/j.jaad.2018.03.056_bib72","first-page":"147","article-title":"Cicatricial alopecia secondary to radiation therapy: case report and review of the literature","volume":"81","author":"Severs","year":"2008","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2018.03.056_bib73","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","article-title":"Pathobiology of\u00a0chemotherapy-induced hair loss","volume":"14","author":"Paus","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2018.03.056_bib74","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/bies.201300166","article-title":"Human epithelial hair follicle stem cells and their progeny: current state of knowledge, the widening gap in translational research and future challenges","volume":"36","author":"Purba","year":"2014","journal-title":"Bioessays"},{"key":"10.1016\/j.jaad.2018.03.056_bib75","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/jid.2013.155","article-title":"Keratinocyte stem cells but not melanocyte stem cells are the primary target for radiation-induced hair graying","volume":"133","author":"Aoki","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib76","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3892\/ijmm.2012.1018","article-title":"Damage of hair follicle stem cells and alteration of keratin expression in external radiation-induced acute alopecia","volume":"30","author":"Nanashima","year":"2012","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jaad.2018.03.056_bib77","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.tips.2013.09.001","article-title":"Protection against chemotherapy-induced alopecia: targeting ATP-binding cassette transporters in the hair follicle?","volume":"34","author":"Haslam","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jaad.2018.03.056_bib78","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/1523-1747.ep12479347","article-title":"Radiobiology of the skin: review of some effects on epidermis and hair","volume":"77","author":"Malkinson","year":"1981","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2307\/3572860","article-title":"Persistent impairment of hair growth afters single large doses of x-rays","volume":"43","author":"Malkinson","year":"1970","journal-title":"Radiat Res"},{"key":"10.1016\/j.jaad.2018.03.056_bib80","first-page":"1","article-title":"Molecular genetic and endocrine mechanisms of hair growth","volume":"60","author":"Alonso","year":"2003","journal-title":"Horm Res"},{"key":"10.1016\/j.jaad.2018.03.056_bib81","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/er.2006-0020","article-title":"The hair follicle as an estrogen target and source","volume":"27","author":"Ohnemus","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jaad.2018.03.056_bib82","first-page":"195","article-title":"Influence of estrogens on the androgen metabolism in different subunits of human hair follicles","volume":"11","author":"Niiyama","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib83","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1365-2133.2010.09955.x","article-title":"Female pattern hair loss: beyond an androgenic aetiology?","volume":"163","author":"Langan","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib84","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/archderm.135.8.973","article-title":"Hair follicle biology, the sebaceous gland, and scarring alopecias","volume":"135","author":"Stenn","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib85","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/jid.2008.425","article-title":"Scarring alopecia and the PPAR-gamma connection","volume":"129","author":"Harries","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib86","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0022-202X.2004.23237.x","article-title":"Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia","volume":"123","author":"Hadshiew","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib87","first-page":"1197","article-title":"Measurement of chemotherapy-induced alopecia-time to change","volume":"23","author":"van den Hurk","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jaad.2018.03.056_bib88","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/2347-5625.152404","article-title":"Familiarity, opinions, experiences and knowledge about scalp cooling: a Dutch survey among breast cancer patients and oncological professionals","volume":"2","author":"Peerbooms","year":"2015","journal-title":"Asia Pac J Oncol Nurs"},{"key":"10.1016\/j.jaad.2018.03.056_bib89","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2165\/00128071-200304110-00004","article-title":"Optimal management of hair loss (alopecia) in children","volume":"4","author":"Harrison","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib90","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1099-1611(199706)6:2<85::AID-PON247>3.0.CO;2-T","article-title":"Side effects of adjuvant chemotherapy: perceptions of node-negative breast cancer patients","volume":"6","author":"Beisecker","year":"1997","journal-title":"Psychooncology"},{"key":"10.1016\/j.jaad.2018.03.056_bib91","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.jaad.2010.11.042","article-title":"Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia","volume":"66","author":"Reid","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.03.056_bib92","first-page":"483","article-title":"Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy","volume":"26","author":"Smith","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jaad.2018.03.056_bib93","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.2016.20939","article-title":"Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: the SCALP randomized clinical trial","volume":"317","author":"Nangia","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2018.03.056_bib94","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10549-017-4185-9","article-title":"Scalp cooling with adjuvant\/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis","volume":"163","author":"Rugo","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jaad.2018.03.056_bib95","doi-asserted-by":"crossref","unstructured":"Freites-Martinez A, Chan D, Sibaud V, et al. Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia. JAMA Dermatology. https:\/\/doi.org\/10.1001\/jamadermatol.2018.5071. Published online March 6, 2019.","DOI":"10.1001\/jamadermatol.2018.5071"},{"key":"10.1016\/j.jaad.2018.03.056_bib96","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10549-018-4996-3","article-title":"Safety of 5alpha-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies","volume":"174","author":"Rozner","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jaad.2018.03.056_bib97","first-page":"17","article-title":"Endocrinology update: hirsutism","volume":"451","author":"Heidelbaugh","year":"2016","journal-title":"FP Essent"},{"key":"10.1016\/j.jaad.2018.03.056_bib98","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000350685","article-title":"Successful Nd:YAG laser therapy for hair removal in the oral cavity after plastic reconstruction using hairy donor sites","volume":"226","author":"Kaune","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2018.03.056_bib99","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1148\/radiol.2542082312","article-title":"Fluoroscopically guided interventional procedures: a review of radiation effects on patients' skin and hair","volume":"254","author":"Balter","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jaad.2018.03.056_bib100","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4252\/wjsc.v7.i4.711","article-title":"Epidermal stem cells and skin tissue engineering in hair follicle regeneration","volume":"7","author":"Balana","year":"2015","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.jaad.2018.03.056_bib101","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1517\/14712598.2013.739601","article-title":"Therapeutic strategy\u00a0for hair regeneration: hair cycle activation, niche environment modulation, wound-induced follicle neogenesis, and stem cell engineering","volume":"13","author":"Chueh","year":"2013","journal-title":"Exp Opin Biol Ther"},{"key":"10.1016\/j.jaad.2018.03.056_bib102","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0974-7753.90809","article-title":"The role of bimatoprost eyelash gel in chemotherapy-induced madarosis: an analysis of efficacy and safety","volume":"3","author":"Morris","year":"2011","journal-title":"Int J Trichology"},{"key":"10.1016\/j.jaad.2018.03.056_bib103","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/pon.4308","article-title":"Psychosocial effects of a skin camouflage program in female survivors with head and neck cancer: a randomized controlled trial","volume":"26","author":"Chen","year":"2017","journal-title":"Psychooncology"},{"key":"10.1016\/j.jaad.2018.03.056_bib104","first-page":"981","article-title":"Effectiveness of cosmetic rehabilitation on the body image of oral cancer patients in Taiwan","volume":"16","author":"Huang","year":"2008","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jaad.2018.03.056_bib105","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaad.2014.09.058","article-title":"Primary cicatricial alopecia: Lymphocytic primary cicatricial alopecias, including chronic cutaneous lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia, and Graham-Little syndrome","volume":"75","author":"Bolduc","year":"2016","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218305309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218305309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:50:46Z","timestamp":1759272646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218305309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0190962218305309"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.03.056","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hair disorders in cancer survivors","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.03.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(19)30479-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}